Published • loading... • Updated
Replimune to Present at Two Upcoming Investor Conferences
Summary by Enid News & Eagle
2 Articles
2 Articles
Reposted by
Enid News & Eagle
Replimune to Present at Two Upcoming Investor Conferences
WOBURN, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that members from the Replimune management team will present and host investor meetings…
·Nebraska, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium

